Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Autolus Therapeutics	Freeline Therapeutics	Proteon Therapeutics	Opthea	CASI Pharmaceuticals
Symbol	NASDAQ:AUTL	NASDAQ:FRLN	NASDAQ:PRTO	NASDAQ:OPT	NASDAQ:CASI
Price Information
Current Price	$6.88	$15.61	$18.01	$10.56	$2.65
52 Week Range	Buy	Buy	N/A	Buy	Buy
MarketRank™
Overall Score	1.2	0.7	0.8	1.5	1.5
Analysis Score	3.4	0.0	0.0	3.4	3.5
Community Score	2.4	2.2	2.6	4.2	2.5
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.8	0.8	0.0	0.8
Earnings & Valuation Score	0.0	0.6	0.6	0.0	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	N/A	Buy	Buy
Consensus Price Target	$21.71	$27.67	N/A	$36.00	$4.25
% Upside from Price Target	215.61% upside	77.24% upside	N/A	240.91% upside	60.38% upside
Trade Information
Market Cap	$359.48 million	$390.41 million	$399.44 million	$458.81 million	$314.82 million
Beta	1.75	N/A	0.6	N/A	0.41
Average Volume	909,647	7,402	1,113,217	14,556	536,581
Sales & Book Value
Annual Revenue	$2.91 million	N/A	N/A	N/A	$4.13 million
Price / Sales	123.53	N/A	N/A	N/A	79.53
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$5.67 per share	N/A	($0.06) per share	N/A	$0.76 per share
Price / Book	1.21	N/A	N/A	N/A	3.49
Profitability
Net Income	$-123,850,000.00	N/A	$-20,730,000.00	N/A	$-46,030,000.00
EPS	($2.88)	N/A	($1.15)	N/A	($0.42)
Trailing P/E Ratio	N/A	0.00	N/A	0.00	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-8,652.90%	N/A	N/A	N/A	-402.87%
Return on Equity (ROE)	-54.01%	N/A	N/A	N/A	-60.96%
Return on Assets (ROA)	-44.19%	N/A	-118.68%	N/A	-42.48%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	N/A	N/A
Current Ratio	7.43%	N/A	5.98%	N/A	14.99%
Quick Ratio	7.43%	N/A	5.98%	N/A	14.86%
Ownership Information
Institutional Ownership Percentage	22.86%	38.48%	23.03%	N/A	31.95%
Insider Ownership Percentage	N/A	N/A	45.70%	N/A	24.75%
Miscellaneous
Employees	290	200	17	N/A	125
Shares Outstanding	52.25 million	25.92 million	22.18 million	42.21 million	123.94 million
Next Earnings Date	3/4/2021 (Confirmed)	N/A	N/A	N/A	3/15/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources